Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002412994 | SCV002717121 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-12-12 | criteria provided, single submitter | clinical testing | The c.185_196del12insA pathogenic mutation, located in coding exon 2 of the CDKN2A gene, results from the deletion of 12 nucleotides and insertion of one nucleotide causing a translational frameshift with a predicted alternate stop codon (p.L62Qfs*54). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |